1-8 of 8
Lazaros Lekakis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and safety of frail adults treated with ciltacabtagene autoleucel in the real-world: A CIBMTR analysis

Free
Hira Mian, Muhammad Salman Faisal, Tiening Chen, Ruta Brazauskas, Temitope Oloyede, Nausheen Ahmed, Aimaz Afrough, Larry Anderson, Rahul Banerjee, Jesús Berdeja, Aram Bidikian, Jakob Devos, Binod Dhakal, Ajoy Dias, Danai Dima, Yvonne Efebera, Lohith Gowda, Doris Hansen, Hamza Hashmi, Heather Landau, Lazaros Lekakis, Abu-Sayeef Mirza, Ravi Narra, Krina Patel, Ashley Rosko, Mark Schroeder, Surbhi Sidana, Saad Usmani, Marcelo Pasquini, Othman Akhtar, Taiga Nishihori, Meera Mohan
Journal: Blood
Blood (2025) 146 (Supplement 1): 133.
https://doi.org/10.1182/blood-2025-133
Published: 2025
Journal Articles

Mosunetuzumab and polatuzumab combined with axicabtagene ciloleucel induce high complete response rates at day+90 in Relapsed/Refractory large B-cell lymphoma

Free
Jay Spiegel, Juan Alderuccio, Amer Beitinjaneh, Trent Wang, Noa Holtzman, Denise Pereira, Mark Goodman, Antonio Jimenez Jimenez, Cara Benjamin, Alvaro Alencar, Georgios Pongas, Izidore S. Lossos, Joseph Rosenblatt, Jonathan Schatz, Michele Stanchina, Asaad Trabolsi, Juan Carlos Ramos, Craig Moskowitz, Robby Friedman, Keerthi Paladugu, Michelle Menard, Damian Green, Lazaros Lekakis
Journal: Blood
Blood (2025) 146 (Supplement 1): 1009.
https://doi.org/10.1182/blood-2025-1009
Published: 2025
Journal Articles

RGI-2001 for the prophylaxis of acute graft-versus-host disease after allogeneic HCT

Available to Purchase
Clinical Trials & Observations
Zachariah DeFilipp, Hannah Choe, Yvonne A. Efebera, Ayman Saad, Shatha Farhan, Lazaros Lekakis, Jean A. Yared, Gary Schiller, Markus Y. Mapara, Amer Assal, Ted Gooley, Jack D. Bui, Dana Lee, Hayley Lane, Yi-Bin Chen
Journal: Blood
Blood (2025) 146 (17): 2037–2046.
https://doi.org/10.1182/blood.2025029584
Published: 2025
Includes: Supplemental data
Journal Articles

Itacitinib for the prevention of IEC therapy–associated CRS: results from the 2-part phase 2 INCB 39110-211 study

Available to Purchase
Clinical Trials & Observations
Matthew J. Frigault, Richard T. Maziarz, Jae H. Park, Aleksandr Lazaryan, Nirav N. Shah, Jakub Svoboda, Lazaros Lekakis, Ran Reshef, Christine L. Phillips, Lea Burke, Jing Lei, Michael Pratta, Rodica Morariu-Zamfir, John F. DiPersio
Journal: Blood
Blood (2025) 146 (4): 422–436.
https://doi.org/10.1182/blood.2024026586
Published: 2025
Includes: Supplemental data
Journal Articles

Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel therapy

Free
Clinical Trials & Observations
Jay Y. Spiegel, Saurabh Dahiya, Michael D. Jain, John Tamaresis, Loretta J. Nastoupil, Miriam T. Jacobs, Armin Ghobadi, Yi Lin, Matthew Lunning, Lazaros Lekakis, Patrick Reagan, Olalekan Oluwole, Joseph McGuirk, Abhinav Deol, Andre Goy, Khoan Vu, Charalambos Andreadis, Javier Munoz, N. Nora Bennani, Julie M. Vose, Kathleen A. Dorritie, Sattva S. Neelapu, Frederick L. Locke, Aaron P. Rapoport, Brian T. Hill, David B. Miklos
Journal: Blood
Blood (2021) 137 (13): 1832–1835.
https://doi.org/10.1182/blood.2020006245
Published: 2021
Includes: Supplemental data
Journal Articles

Long-term course of patients with primary ocular adnexal MALT lymphoma: a large single-institution cohort study

Free
Clinical Trials & Observations
Amrita Desai, Madhura G. Joag, Lazaros Lekakis, Jennifer R. Chapman, Francisco Vega, Robert Tibshirani, David Tse, Arnold Markoe, Izidore S. Lossos
Journal: Blood
Blood (2017) 129 (3): 324–332.
https://doi.org/10.1182/blood-2016-05-714584
Published: 2017
Journal Articles

Kte-C19 (anti-CD19 CAR T Cells) Induces Complete Remissions in Patients with Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Results from the Pivotal Phase 2 Zuma-1

Free
Sattva S. Neelapu, MD, Frederick L. Locke, MD, Nancy L. Bartlett, MD, Lazaros Lekakis, MD, David Miklos, MD PhD, Caron A. Jacobson, MD, Ira Braunschweig, MD, Olalekan Oluwole, MBBS, MPH, Tanya Siddiqi, MD, Yi Lin, MD PhD, John Timmerman, MD, Patrick J. Stiff, Jonathan Friedberg, MD, Ian Flinn, Andre Goy, MD, Mitchell Smith, Abhinav Deol, MD, Umar Farooq, MD, Peter McSweeney, MD, Javier Munoz, MD, Irit Avivi, MD, Januario E. Castro, MD, Jason R. Westin, MD MS, Julio C. Chavez, MD, Armin Ghobadi, MD, Krishna V. Komanduri, MD, Ronald Levy, MD, Eric D. Jacobsen, Patrick Reagan, MD, Adrian Bot, MD PhD, John M. Rossi, MS, Lynn Navale, MS, Yizhou Jiang, PhD, Jeff S. Aycock, BA, Meg Elias, RN, BSN, Jeff Wiezorek, MD MS, William Y. Go, MD PhD
Journal: Blood
Blood (2016) 128 (22): LBA-6.
https://doi.org/10.1182/blood.V128.22.LBA-6.LBA-6
Published: 2016
Journal Articles

Phase I Study of the Novel Surivin and cdc2/CDK1 Inhibitor Terameprocol in Patients with Advanced Leukemias.

Free
Raoul Tibes, MD, PhD, Kevin T. McDonagh, MD, Lazaros Lekakis, MD, Neal Frazer, MD, Scott Mohrland, PhD, Bassett Dawn, RN, Reynaldo Garcia, RN, OCN, Katy Schroeder, RN, Vijayalakshmi Shanmugam, John Carpten, Daniel Von Hoff, MD, FACP, Thomas C. Shea, MD
Journal: Blood
Blood (2009) 114 (22): 1039.
https://doi.org/10.1182/blood.V114.22.1039.1039
Published: 2009